Caroline Leijonhufvud

2PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 20, 2024
Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity.

Laura Sanz-Ortega, Caroline Leijonhufvud, Lisanne Schoutens

|Jan 19, 2024
KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity.

Caroline Leijonhufvud, Laura Sanz-Ortega, Heinrich Schlums

Pageof 1

Frequent Collaborators

1 joint publications

Ahmed Gaballa

1 joint publications

Michael Uhlin

1 joint publications

Laura Sanz-Ortega

1 joint publications

Lisanne Schoutens